Begin main content

Reports

We found 5792 result(s)

dupilumab (Dupixent)

Last Updated: October 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dupilumab
Indications: atopic dermatitis

  • Brand Name: Dupixent
  • Manufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0636-000
  • Project Status: Received
  • Submission Type: New

telotristat (Xermelo)

Last Updated: October 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: telotristat
Indications: carcinoid syndrome

  • Brand Name: Xermelo
  • Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
  • Project Number: SR0580-000
  • Project Status: Complete
  • Submission Type: New

siponimod (Mayzent)

Last Updated: October 22, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: siponimod
Indications: Secondary progressive multiple sclerosis

  • Brand Name: Mayzent
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0631-000
  • Project Status: Active
  • Submission Type: New

onabotulinumtoxinA (Botox)

Last Updated: October 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: onabotulinumtoxinA
Indications: Migraine, chronic

  • Brand Name: Botox
  • Manufacturer: Allergan Canada Inc.
  • Project Number: SR0584-000
  • Project Status: Active
  • Submission Type: Resubmission

dolutegravir / lamivudine (Dovato)

Last Updated: October 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dolutegravir / lamivudine
Indications: HIV-1 infection

  • Brand Name: Dovato
  • Manufacturer: ViiV Healthcare
  • Project Number: SR0601-000
  • Project Status: Complete
  • Submission Type: New

brolucizumab (TBC)

Last Updated: October 22, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: brolucizumab
Indications: Macular degeneration, age-related

  • Brand Name: TBC
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0632-000
  • Project Status: Received
  • Submission Type: New